Merck & Co., Inc., Kenilworth, N.J., U.S.A., known as MSD outside the United States of America and Canada, ranks #3 with a brand value of USD $13.880 billion. The company operates in more than 140 countries.
Its corporate brand exhibits an above average impact on healthcare professional (HCP) decision-making relative to its peers, driven by a legacy of making significant contributions to healthcare. The HCPs surveyed view Merck & Co., Inc., Kenilworth, N.J., U.S.A., as a thought leader in the industry and a go-to source for expert knowledge.
The company focuses on a range of targeted therapeutic areas including diabetes, cardiovascular disease, infectious diseases, Alzheimer’s disease, and oncology. Merck & Co., Inc., Kenilworth, N.J., U.S.A., also operates a large animal health business.
The company is celebrating its 125-year anniversary in 2016 and is dedicated to reinforcing its reputation as an innovative and life-changing healthcare company, while focusing the company on its inventions of the future.